R&D Cassava’s Alzheimer’s drug nears P3 readout, but SEC scandal... Cassava is advancing simufilam through a pivotal phase 3 trial, despite lingering controversy from a SEC investigation.
R&D Challenges and opportunities in synthetic clinical trials Of the many changes coming to clinical trials, one of the biggest potential paradigm shifts on the horizon is the elimination of placebo groups in some trials in favour of synthetic control
Digital Transitioning PROs from paper to digital: Maintaining data i... Patient-reported outcomes (PROs) provide important insights for clinical trials.
Partner Content Partner Content Integrity Matters: The Importance of Data Integrity in Pharm... Data Integrity
News Partner of ex-Theranos CEO raising cash for testing startup The partner of disgraced ex-Theranos CEO Elizabeth Holmes, Billy Evans, has reportedly raised millions of dollars for another blood testing startup.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
